series-a
Stage
2022
Founded
3
Investors
About
ArkeaBio develops a safe, cost-effective methane reducing vaccine to lower emissions from cattle worldwide, targeting methanogenic archaea in the rumen to disrupt methane production at its microbial source.
Explore ArkeaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.